ATP

ATP consists of adenine joined to ribose, forming adenosine, with three phosphate groups attached in series ^[1]. Its central role is to power the enormous number of energy-requiring reactions in cells: breaking the bond to the terminal phosphate converts ATP to ADP and inorganic phosphate and liberates free energy that enzymes couple to work such as biosynthesis, molecular transport, and muscle contraction ^[1]. The molecule is continuously regenerated; over a day the human body turns over an amount of ATP comparable to its own weight, recycling each molecule many times rather than storing large quantities ^[1].

Cells make ATP through several pathways, including substrate-level phosphorylation in glycolysis, the citric acid cycle, and, most productively, oxidative phosphorylation in the mitochondria, where the electron transport chain drives the enzyme ATP synthase; plants and other photosynthetic organisms also make it using light energy ^[1]. ATP is far more than a fuel: it is the phosphate donor for the protein kinases that run signaling cascades, a precursor of the second messenger cyclic AMP, and one of the nucleotide building blocks used to synthesize RNA ^[1]. Outside the cell, released ATP and its breakdown products act on purinergic receptors, contributing to functions such as neurotransmission and the regulation of blood flow ^[2].

ATP was first isolated from muscle in 1929, and its role as the universal energy intermediary was recognized over the following decades, work later honored with several Nobel Prizes. As a consumer product, oral ATP is sold as a dietary supplement, often marketed for exercise performance and recovery. Small controlled studies of oral ATP have reported modest effects, such as reduced muscle fatigue and better maintenance of force at the end of exhausting exercise ^[2], and improved post-exercise blood pressure and heart-rate recovery in one trial ^[3]; the overall evidence base remains limited. Because swallowed ATP is largely broken down in digestion rather than absorbed intact, its reported benefits are generally attributed to downstream metabolites and signaling rather than to directly raising ATP inside cells ^[2].

Oral adenosine triphosphate is used as a performance supplement and is generally well tolerated in short-term studies; because ingested ATP is largely broken down during digestion, systemic effects are modest. Reported adverse effects are minor and may include gastrointestinal discomfort, and long-term human safety data are limited.

Adenosine triphosphate was first isolated from muscle in 1929, independently by Karl Lohmann in Germany and by Cyrus Fiske and Yellapragada Subbarow in the United States. In 1941 Fritz Lipmann articulated the concept that ATP serves as the universal carrier of chemical energy in the cell, linking energy-releasing and energy-consuming reactions. The molecule was chemically synthesized by Alexander Todd in 1948, and the enzymatic machinery that regenerates it, ATP synthase, was later elucidated by Paul Boyer and John Walker, who shared the 1997 Nobel Prize in Chemistry for that work. Interest in ATP as an oral supplement is much more recent, emerging in the 2000s as researchers explored its extracellular signaling roles.

ATP is universally recognized in biochemistry as the cell's energy currency, one of the most fundamental molecules in all of life. As a supplement its reputation is more modest but genuinely intriguing; because ingested ATP is broken down before it can reach the bloodstream, any benefit is attributed to extracellular signaling that promotes blood flow and supports recovery rather than to simply adding fuel. A small but reasonably consistent set of human trials points to modest gains in strength and fatigue resistance during demanding training. It is best understood as a niche ergogenic aid with an interesting mechanism, valued by those experimenting at the margins of performance.